These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 11187394)

  • 1. Lipid-lowering and antiatherosclerotic effect of NK-104, a potent 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits.
    Suzuki H; Yamazaki H; Aoki T; Kojima J; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2000 Nov; 50(11):995-1003. PubMed ID: 11187394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of fluvastatin sodium on the smooth muscle cells in atherosclerotic plaques. In vivo study using low-density lipoprotein receptor deficient Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Shiomi M; Ito T; Tsukada T; Shiraishi M; Yata T
    Arzneimittelforschung; 1998 Jun; 48(6):680-5. PubMed ID: 9689427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypolipidemic effect of NK-104 and other 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in guinea pigs.
    Suzuki H; Yamazaki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2001 Jan; 51(1):38-45. PubMed ID: 11215324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol-lowering effect of NK-104, a 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, in guinea pig model of hyperlipidemia.
    Aoki T; Yamazaki H; Suzuki H; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2001; 51(3):197-203. PubMed ID: 11304935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced aortic atherosclerosis in transgenic Watanabe heritable hyperlipidemic rabbits expressing lipoprotein lipase.
    Koike T; Liang J; Wang X; Ichikawa T; Shiomi M; Sun H; Watanabe T; Liu G; Fan J
    Cardiovasc Res; 2005 Feb; 65(2):524-34. PubMed ID: 15639492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plaque-stabilizing effect of pitavastatin in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Suzuki H; Kobayashi H; Sato F; Yonemitsu Y; Nakashima Y; Sueishi K
    J Atheroscler Thromb; 2003; 10(2):109-16. PubMed ID: 12740485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase.
    Aoki T; Nishimura H; Nakagawa S; Kojima J; Suzuki H; Tamaki T; Wada Y; Yokoo N; Sato F; Kimata H; Kitahara M; Toyoda K; Sakashita M; Saito Y
    Arzneimittelforschung; 1997 Aug; 47(8):904-9. PubMed ID: 9296275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of fluvastatin sodium on secretion of very low density lipoprotein and serum cholesterol levels. In vivo study using low density lipoprotein receptor deficient watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Shiraishi M; Yata T; Ito T
    Arzneimittelforschung; 1994 Oct; 44(10):1154-6. PubMed ID: 7818592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of HR780, a novel 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in Watanabe heritable hyperlipidemic rabbits and cholesterol-fed rabbits.
    Wajima T; Makita S; Oshima K
    Pharmacology; 2004 Mar; 70(3):123-9. PubMed ID: 14752232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pravastatin inhibits expression of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in Watanabe heritable hyperlipidemic rabbits: a new pleiotropic effect of statins.
    Hofnagel O; Luechtenborg B; Eschert H; Weissen-Plenz G; Severs NJ; Robenek H
    Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):604-10. PubMed ID: 16373606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of cerivastatin sodium, a new inhibitor of HMG-CoA reductase, on plasma lipid levels, progression of atherosclerosis, and the lesional composition in the plaques of WHHL rabbits.
    Shiomi M; Ito T
    Br J Pharmacol; 1999 Feb; 126(4):961-8. PubMed ID: 10193776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High dose of fluvastatin sodium (XU62-320), a new inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, lowers plasma cholesterol levels in homozygous Watanabe-heritable hyperlipidemic rabbits.
    Kurokawa J; Hayashi K; Toyota Y; Shingu T; Shiomi M; Kajiyama G
    Biochim Biophys Acta; 1995 Oct; 1259(1):99-104. PubMed ID: 7492622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of very low density lipoprotein receptor mRNA in rabbit atherosclerotic lesions.
    Nakazato K; Ishibashi T; Shindo J; Shiomi M; Maruyama Y
    Am J Pathol; 1996 Dec; 149(6):1831-8. PubMed ID: 8952520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of pitavastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, in patients with hyperlipidemia. Dose-finding study using the double-blind, three-group parallel comparison.
    Saito Y; Yamada N; Teramoto T; Itakura H; Hata Y; Nakaya N; Mabuchi H; Tushima M; Sasaki J; Goto Y; Ogawa N
    Arzneimittelforschung; 2002; 52(4):251-5. PubMed ID: 12040967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anthocyanins increase low-density lipoprotein and plasma cholesterol and do not reduce atherosclerosis in Watanabe Heritable Hyperlipidemic rabbits.
    Finné Nielsen IL; Elbøl Rasmussen S; Mortensen A; Ravn-Haren G; Ma HP; Knuthsen P; Hansen BF; McPhail D; Freese R; Breinholt V; Frandsen H; Dragsted LO
    Mol Nutr Food Res; 2005 Apr; 49(4):301-8. PubMed ID: 15759306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pravastatin sodium, a competitive inhibitor of hepatic 3-hydroxy-3-methylglutaryl coenzyme A reductase, decreases the cholesterol content of newly secreted very-low-density lipoprotein in Watanabe heritable hyperlipidemic rabbits.
    Shiomi M; Ito T
    Metabolism; 1994 May; 43(5):559-64. PubMed ID: 8177044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triglyceride-lowering effect of pitavastatin in a guinea pig model of postprandial lipemia.
    Aoki T; Yamazaki H; Tamaki T; Sato F; Kitahara M; Saito Y
    Arzneimittelforschung; 2003; 53(3):154-8. PubMed ID: 12705169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-lipid deposition effect of HMG-CoA reductase inhibitor, pitavastatin, in a rat model of hypertension and hypercholesterolemia.
    Kumai T; Oonuma S; Matsumoto N; Takeba Y; Taniguchi R; Kamio K; Miyazu O; Koitabashi Y; Sekine S; Tadokoro M; Kobayashi S
    Life Sci; 2004 Mar; 74(17):2129-42. PubMed ID: 14969717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypolipidemic effect of NK-104, a potent HMG-CoA reductase inhibitor, in guinea pigs.
    Suzuki H; Aoki T; Tamaki T; Sato F; Kitahara M; Saito Y
    Atherosclerosis; 1999 Oct; 146(2):259-70. PubMed ID: 10532682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pravastatin decreases serum lipids and vascular cholesterol deposition in Watanabe heritable hyperlipidemic (WHHL) rabbits.
    Khachadurian AK; Shimamura T; Rozovski SJ; Ananthakrishnan R; Armenian B; Coly E; alHinai A; Martucci C; Schneider SH; Amorosa LF
    Jpn Heart J; 1991 Sep; 32(5):675-85. PubMed ID: 1774829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.